C061P: Ramucirumab Biosimilar, Human VEGFR2 Monoclonal Antibody
Recombinant Human IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The monoclonal antibody ramucirumab biosimilar specifically binds to the human VEGFR2 (KDR).
Applications: ELISA, flow cytometry, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by ramucirumab.PA000099-PA1399: VEGFR1/FLT1 Polyclonal Antibody
Rabbit Polyclonal Antibody;
Applications: WB;
Reactivity: Human;
Isotype: Rabbit IgG.PA000099-PA1966: FLT1/VEGFR1 Polyclonal Antibody
Rabbit Polyclonal Antibody;
Applications: WB;
Reactivity: Rat;
Isotype: Rabbit IgG.PA000100-MA1040: VEGFR2 Monoclonal Antibody
Mouse Monoclonal Antibody;
Applications: WB, IHC, IF;
Reactivity: Human;
Clone: FLK-6;
Isotype: Mouse IgG1.BP000995-PKA-242: Recombinant Human VEGFR2
Source:Insect Cells-derived.
The activity of VEGFR2 D1-7 was determined by its ability to abolish the binding of iodinated VEGF to solid surfaces or cell surfaces receptors. The ED50 for this effect is typically 10.0 ng/ml, corresponding to a specific activity of 100,000 IU/mg.
Purity > 95%, by SDS-PAGE.BP000995-PKA-243: Recombinant Human VEGFR2 Fc Chimera
Source:Insect Cells-derived.
The activity of sVEGFR-2/Fc was determined by its ability to inhibit the VEGF-dependent proliferation of human umbilical vein endothelial cells. The ED50 for this effect is typically 10-30 ng/ml, corresponding to a specific activity of 33,333.33-100,000 units/mg.
Purity > 90%, by SDS-PAGE.